Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10688729.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pemphigus foliaceus is an autoimmune blistering disease of unknown origin with antibodies produced against desmoglein 1, an adhesive protein found in the desmosomal cell junction in the suprabasal layers of the epidermis. The disease is primarily treated with corticosteroids and corticosteroid-sparing immunosuppressive agents. We report a case of pemphigus foliaceus successfully treated with mycophenolate mofetil. It remains to be seen whether this agent has a significant effect on the course of the disease and remission induction.
Medical subject headings
- Enzyme Inhibitors
- Facial Dermatoses
- Immunosuppressive Agents
- Mycophenolic Acid
- Pemphigus
- Prodrugs